Članci s nalozima za javni pristup - Takafumi TakaiSaznajte više
Dostupno negdje: 3
Discovery of a novel B-cell lymphoma 6 (BCL6)–corepressor interaction inhibitor by utilizing structure-based drug design
T Yasui, T Yamamoto, N Sakai, K Asano, T Takai, Y Yoshitomi, M Davis, ...
Bioorganic & Medicinal Chemistry 25 (17), 4876-4886, 2017
Nalozi: US Department of Energy, US National Institutes of Health
Discovery and optimization of 1, 7-disubstituted-2, 2-dimethyl-2, 3-dihydroquinazolin-4 (1H)-ones as potent and selective PKCθ inhibitors
T Katoh, T Takai, T Yukawa, T Tsukamoto, E Watanabe, H Mototani, ...
Bioorganic & Medicinal Chemistry 24 (11), 2466-2475, 2016
Nalozi: US Department of Energy, US National Institutes of Health
Structure-based design, synthesis, and biological evaluation of imidazo [1, 2-b] pyridazine-based p38 MAP kinase inhibitors
A Kaieda, M Takahashi, T Takai, M Goto, T Miyazaki, Y Hori, S Unno, ...
Bioorganic & Medicinal Chemistry 26 (3), 647-660, 2018
Nalozi: US Department of Energy, US National Institutes of Health, Howard Hughes …
Publikacije i informacije o financiranju automatski određuje računalni program